Elfriede Noessner

Prof. Elfriede Noessner

Helmholtz Center Munich
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2011 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
AMAnna N. Mendler
Anna N. Mendler
BHBin Hu
Bin Hu
PPPetra U. Prinz
Petra U. Prinz
MKMarina Kreutz
Marina Kreutz
EGEva Gottfried
Eva Gottfried
ENElfriede Noessner
Elfriede Noessner
Lactic acidosis is common to most solid tumors and has been found to affect infiltrating immune cells. Here we document effector phase inhibition of cytotoxic T cells (CTLs) involving complete blockage of cytokine production and partial impairment of lytic granule exocytosis. Lactic acidosis impaired TCR‐triggered phosphorylation of JNK, c‐Jun and p38, while not affecting MEK1 and ERK. The select targeting of signaling proteins involved in IFNγ production (JNK/c‐Jun, p38) without affecting those jointly used in cytokine regulation and granule exocytosis (MEK1/ERK) explains the observed split effect of lactic acidosis on the CTL responses. CTL inhibition by lactic acidosis showed fast dynamics with immediate onset and reversion. Functional recovery by neutralizing the extracellular pH despite continuous presence of lactate holds promise that CTL activity can be improved in the milieu of solid tumors with appropriate anti‐acidosis treatment, thereby increasing the efficacy of adoptive T cell therapy.

26 August 2011 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
JEJudith Eckl
Judith Eckl
ABAlexander Buchner
Alexander Buchner
PPPetra U. Prinz
Petra U. Prinz
RRRainer Riesenberg
Rainer Riesenberg
SSSabine I. Siegert
Sabine I. Siegert
ENElfriede Noessner
Elfriede Noessner

8 June 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
MMMadhura Modak
Madhura Modak
AMAnn-Kathrin Mattes
Ann-Kathrin Mattes
DRDaniela Reiss
Daniela Reiss
WSWioletta Skronska-Wasek
Wioletta Skronska-Wasek
RLRebecca Langlois
Rebecca Langlois
SPStefan Pflanz
Stefan Pflanz
In many solid cancers, tumor-associated macrophages (TAM) represent the predominant myeloid cell population. Antigen (Ag) cross-presentation leading to tumor Ag–directed cytotoxic CD8 + T cell responses is crucial for antitumor immunity. However, the role of recruited monocyte-derived macrophages, including TAM, as potential cross-presenting cells is not well understood. Here, we show that primary human as well as mouse CD206 + macrophages are effective in functional cross-presentation of soluble self-Ag and non–self-Ag, including tumor-associated Ag (TAA), as well as viral Ag. To confirm the presence of cross-presenting TAM in vivo, we performed phenotypic and functional analysis of TAM from B16-F10 and CT26 syngeneic tumor models and have identified CD11b+F4/80hiCD206+ TAM to effectively cross-present TAA. We show that CD11b+CD206+ TAM represent the dominant tumor-infiltrating myeloid cell population, expressing a unique cell surface repertoire, promoting Ag cross-presentation and Ag-specific CD8+ T cell activation comparable with cross-presenting CLEC9A+ DCs (cDC1). The presence of cross-presenting CD206+ TAM is associated with reduced tumor burden in mouse syngeneic tumor models and with improved overall survival in cutaneous melanoma patients. Therefore, the demonstration of effective Ag cross-presentation capabilities of CD206+ TAM, including their clinical relevance, expands our understanding of TAM phenotypic diversity and functional versatility.

4 November 2012 in OncoImmunology
Verified
Journal Article
Open access
ENElfriede Noessner
Elfriede Noessner
DBDorothee Brech
Dorothee Brech
AMAnna N. Mendler
Anna N. Mendler
IMIlias Masouris
Ilias Masouris
RSRamona Schlenker
Ramona Schlenker
PPPetra U. Prinz
Petra U. Prinz
Cytotoxic lymphocytes and dendritic cells infiltrating human renal cell carcinoma (RCC) are not sufficient to prevent tumor progression. Our studies identified alterations of the immune cell infilt...

11 March 2014 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
PPPetra U. Prinz
Petra U. Prinz
AMAnna N. Mendler
Anna N. Mendler
DBDorothee Brech
Dorothee Brech
IMIlias Masouris
Ilias Masouris
RORalph Oberneder
Ralph Oberneder
ENElfriede Noessner
Elfriede Noessner
The relevance of NK cells in tumor control is well established in mouse models and human hematologic malignancies; however, their contribution to the control of human solid tumors remains disputed due to problems with in situ detection and reports of functional inactivity in the tumor milieu. In this study, we established a reliable in situ detection method for NK cells. Moreover, we performed analysis to elucidate mechanisms that impair NK-cell function in the tumor milieu and thereby identify therapeutic targets that allow recovery of NK-cell functionality. It was observed that NK cells from clear cell renal cell carcinoma (ccRCC), compared to NK cells from nontumor kidney and peripheral blood lymphocytes (PBLs), displayed conjoint phenotypic alterations and dysfunction induced by the tumor milieu, which were associated mechanistically with high levels of signaling attenuator diacylglycerol kinase (DGK)-α and blunted mitogen-activated protein kinase pathway activation (ERK1/2, Jun kinase). Reinstating NK-cell functionality was possible by DGK inhibition or brief IL-2 culture, interventions that de-repressed the ERK pathway. The extent of alteration and magnitude of recovery could be linked to NK-cell frequency within ccRCC-infiltrating lymphocytes, possibly explaining the observed survival benefit of patients with NKhigh tumors. In conclusion, DGK-mediated dampening of the ERK pathway ensuing in NK-cell dysfunction was identified as an important escape mechanism in ccRCC. DGK and the ERK pathway thus emerge as promising therapeutic targets to restore suppressed NK-cell activity for the improvement of antitumor immunity.

1 July 2011 in The American Journal of Pathology
Verified
Journal Article
Closed access
AFAinhoa-M. Figel
Ainhoa-M. Figel
DBDorothee Brech
Dorothee Brech
PPPetra U. Prinz
Petra U. Prinz
ULUlrike K. Lettenmeyer
Ulrike K. Lettenmeyer
JEJudith Eckl
Judith Eckl
ENElfriede Noessner
Elfriede Noessner